Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine receptors are a family of G protein-coupled receptors that mediate the physiological actions of the neurotransmitter dopamine. They are widely expressed in the central nervous system and peripheral tissues and are divided into two families: D1-like (D1 and D5) and D2-like (D2, D3, and D4). They regulate motor control, motivation, cognition, emotion, and neuroendocrine secretion, and play key roles in neurological disorders such as Parkinson’s disease, schizophrenia, bipolar disorder, Alzheimer’s disease, and ADHD.
Agonists activate dopamine receptors, mimicking the effects of dopamine. Antagonists block dopamine receptors, preventing dopamine from binding and exerting its effects. Some drugs selectively target specific dopamine receptor subtypes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor (DAR).